You are researching: Organoids
Matching entries: 2 /2
All Groups
AUTHOR Bouwmeester, Manon C. and Bernal, Paulina N. and Oosterhoff, Loes A. and van Wolferen, Monique E. and Lehmann, Vivian and Vermaas, Monique and Buchholz, Maj-Britt and Peiffer, Quentin C. and Malda, Jos and van der Laan, Luc J. W. and Kramer, Nynke I. and Schneeberger, Kerstin and Levato, Riccardo and Spee, Bart
Title Bioprinting of Human Liver-Derived Epithelial Organoids for Toxicity Studies [Abstract]
Year 2021
Journal/Proceedings Macromolecular Bioscience
Abstract There is a need for long-lived hepatic in vitro models to better predict drug induced liver injury (DILI). Human liver-derived epithelial organoids are a promising cell source for advanced in vitro models. Here, organoid technology is combined with biofabrication techniques, which holds great potential for the design of in vitro models with complex and customizable architectures. Here, porous constructs with human hepatocyte-like cells derived from organoids are generated using extrusion-based printing technology. Cell viability of bioprinted organoids remains stable for up to ten days (88–107% cell viability compared to the day of printing). The expression of hepatic markers, transporters, and phase I enzymes increased compared to undifferentiated controls, and is comparable to non-printed controls. Exposure to acetaminophen, a well-known hepatotoxic compound, decreases cell viability of bioprinted liver organoids to 21–51% (p < 0.05) compared to the start of exposure, and elevated levels of damage marker miR-122 are observed in the culture medium, indicating the potential use of the bioprinted constructs for toxicity testing. In conclusion, human liver-derived epithelial organoids can be combined with a biofabrication approach, thereby paving the way to create perfusable, complex constructs which can be used as toxicology- and disease-models.
AUTHOR Juraski, Amanda C. and Sharma, Sonali and Sparanese, Sydney and da Silva, Victor A. and Wong, Julie and Laksman, Zachary and Flannigan, Ryan and Rohani, Leili and Willerth, Stephanie M.
Title 3D bioprinting for organ and organoid models and disease modeling [Abstract]
Year 2023
Journal/Proceedings Expert Opinion on Drug Discovery
ABSTRACTIntroduction 3D printing, a versatile additive manufacturing technique, has diverse applications ranging from transportation, rapid prototyping, clean energy, and medical devices.Areas covered The authors focus on how 3D printing technology can enhance the drug discovery process through automating tissue production that enables high-throughput screening of potential drug candidates. They also discuss how the 3D bioprinting process works and what considerations to address when using this technology to generate cell laden constructs for drug screening as well as the outputs from such assays necessary for determining the efficacy of potential drug candidates. They focus on how bioprinting how has been used to generate cardiac, neural, and testis tissue models, focusing on bio-printed 3D organoids.Expert opinion The next generation of 3D bioprinted organ model holds great promises for the field of medicine. In terms of drug discovery, the incorporation of smart cell culture systems and biosensors into 3D bioprinted models could provide highly detailed and functional organ models for drug screening. By addressing current challenges of vascularization, electrophysiological control, and scalability, researchers can obtain more reliable and accurate data for drug development, reducing the risk of drug failures during clinical trials.